At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax is currently focused on developing an innovative pipeline of combination therapies in multiple cancer indications.
Our lead product candidate, entinostat, which was granted Breakthrough Therapy designation by the U.S. Food and Drug Administration following positive results from our Phase 2b clinical trial, ENCORE 301, is currently being evaluated in a Phase 3 clinical trial for advanced hormone receptor positive breast cancer, and as a combination therapeutic in Phase 1b/2 clinical trials with Merck & Co., Inc. for non-small cell lung cancer and melanoma, with Genentech, Inc. for TNBC, and with Pfizer Inc. and Merck KGaA, Darmstadt, Germany, for ovarian cancer.
Concurrently, Syndax is also developing SNDX-6352 (also known as UCB6352), an IND-ready anti-CSF-1R monoclonal antibody, to potentially enhance the body’s immune response on tumors that have shown sensitivity to immunotherapy. We expect to advance SNDX-6352 into the clinic later this year.
Syndax is headquartered in Waltham, Massachusetts.
The Finance Intern will support the Accounting Department with the following activities:
- Help enter invoices and purchase orders into NetSuite, our GL system
- File invoices and various other documents appropriately
- Provide help on completing expense reports using Concur
- Help on other ad hoc projects are needed
- Great analytical skills
- Microsoft Excel
- Detail oriented personality
We are looking for someone 3 days per week for the summer and have flexibility on working schedule